Citation Impact
Citing Papers
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Second primary malignancies in thyroid cancer patients
2003
Hepatocellular carcinoma
2003 Standout
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Effects of the Antifungal Agents on Oxidative Drug Metabolism
2000
Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial
1998
Role of ROS and RNS Sources in Physiological and Pathological Conditions
2016 Standout
Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by h.p.l.c.‐MS and microparticle enzyme immunoassay (MEIA).
1994
[42] Use of human hepatocytes to study P450 gene induction
1996
Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality
2003 Standout
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Adverse Drug Reactions to Systemic Antifungals Prevention and Management
1992
Cloning and Tissue Distribution of a Novel Human Cytochrome P450 of the CYP3A Subfamily, CYP3A43
2001
Effects of Prototypical Microsomal Enzyme Inducers on Cytochrome P450 Expression in Cultured Human Hepatocytes
2003
Human liver carbamazepine metabolism
1994
Gastrointestinal pH and transit times in healthy subjects with ileostomy
1990
Oral Anticoagulant Therapy
2012 Standout
Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.
1992
Phaeochromocytoma
2005 Standout
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
Organoid Models and Applications in Biomedical Research
2015 Standout
Drug-Induced Hepatotoxicity
2003 Standout
RELATIONSHIP BETWEEN IN VIVO FK506 CLEARANCE AND IN VITRO 13-DEMETHYLATION ACTIVITY IN LIVING-RELATED LIVER TRANSPLANTATION
1998
The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
2005
A Regulatory Cascade of the Nuclear Receptors FXR, SHP-1, and LRH-1 Represses Bile Acid Biosynthesis
2000 Standout
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*
1997 Standout
Adverse Drug Interactions in Anesthesia
1997
Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation
2001
Olive Oil Phenols Are Absorbed in Humans
2002 Standout
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Pharmacokinetics of Haloperidol
1989
Management of Hepatocellular Carcinoma *
2005 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Identification of drugs inhibiting thein vitrometabolism of tacrolimus by human liver microsomes
1996
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo
2011 StandoutNobel
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Mini-series: I. Basic science. Uncertainty and inaccuracy of predicting CYP-mediated in vivo drug interactions in the ICU from in vitro models: focus on CYP3A4
2009
The Endoplasmic Reticulum in Xenobiotic Toxicity
2005
The Ubiquitous Glucose Transporter GLUT-1 Is a Receptor for HTLV
2003
A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload
2001 Standout
Natural History, Treatment, and Course of Papillary Thyroid Carcinoma*
1990 Standout
cyclosporine and liver transplantation: Will the midazolam test make blood level monitoring obsolete?
1995
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
2001 Standout
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
2002 Standout
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
Fish bioaccumulation and biomarkers in environmental risk assessment: a review
2002 Standout
Cultured Rat Hepatocytes
1996
The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine*
1995
Pharmacokinetics of Haloperidol
1999
Pheochromocytoma: Update on Diagnosis, Localization, and Management
1995
Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation
1998 Standout
Cytochrome P450 ω-Hydroxylase Pathway of Tocopherol Catabolism
2002 Standout
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
Clotrimazole increases tacrolimus blood levels: a drug interaction in kidney transplant patients
2001
Herbal Medicines and Perioperative Care
2001 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Inhibition and induction of human cytochrome P450 (CYP) enzymes
1998
Topographic diversity of fungal and bacterial communities in human skin
2013 StandoutNature
Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion
2015
Colchicine Down-Regulates Cytochrome P450 2B6, 2C8, 2C9, and 3A4 in Human Hepatocytes by Affecting Their Glucocorticoid Receptor-Mediated Regulation
2003
Cytochrome P4503A (CYP3A) metabolism: Prediction ofIn Vivo activity in humans
1996
Drug–drug interactions with systemic antifungals in clinical practice
2007
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery
1997
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2012 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid
1988 StandoutNobel
Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
2000 Standout
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
2020 Standout
IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
1998
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Circulating Thyroglobulin and Thyroid Hormones in Patients with Metastases of Differentiated Thyroid Carcinoma: Relationship to Serum Thyrotropin Levels
1980
Chitosan—A versatile semi-synthetic polymer in biomedical applications
2011 Standout
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma
1985
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients
1996
The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug-drug interactions and pharmacological activity of the main metabolite.
1998
Klebsiellaspp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors
1998 Standout
DRUG METABOLISM BY CYTOCHROMES P450 IN THE LIVER AND SMALL BOWEL
1992
The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
2005
Systemic Antifungal Agents
1998
Liver cell models in in vitro toxicology.
1998
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
The Use of Human Hepatocyte Cultures to Study the Induction of Cytochrome P-450
1999
Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes.
1993
Elevated levels of multiple cytochrome P450 forms in tilapia from Billings Reservoir-São Paulo, Brazil
1999
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
2010 StandoutNobel
Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.
1992
C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins
1993
P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans.
1996
Macrolide Antibacterials
1995
Strategies for restoration and maintenance of normal hepatic structure and function in long-term cultures of rat hepatocytes
1996
Works of B Aubert being referenced
Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.
1990
Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study.
1996
Intestinal adaptation in patients with short bowel syndrome
1989
[131I]metaiodobenzylguanidine therapy in 20 patients with malignant pheochromocytoma.
1992
Follow-up of differentiated thyroid cancers after treatment. Resume and practical guide for the development of follow-up programs.
1978
Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma.
1996
Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4
1985